EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Regulatory mechanism of ghrelin on testosterone secretion in type 1 diabetic rats

Chien-Chen Lu iD, Chia-Hsin Chang, Jou-Chun Chou, Po-Ling Yu, Paulus S Wang iD

Reproduction and Fertility · 2025

DOI: 10.1530/raf-24-0087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Reproduction and Fertility, 2025. Verfasst von Chien-Chen Lu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Optometry, MacKay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan. Hauptthemen laut MEDLINE: Testosterone, Ghrelin, Leydig Cells, Diabetes Mellitus, Experimental. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, ROC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ghrelin, which is a hormone composed of 28 amino acids that is mainly produced in the stomach, is also secreted by Leydig cells in the testes of rats and humans. The hypothalamus regulates testosterone secretion by releasing gonadotropin-releasing hormone (GnRH), which stimulates the pituitary gland to release luteinizing hormone (LH). LH then prompts the testes to produce testosterone via the activity of steroidogenic acute regulatory protein (StAR). Consequently, ghrelin may play a regulatory role in gonadal function. Male Sprague–Dawley rats were randomly assigned to four groups: the control, ghrelin-treated, diabetic, and diabetic plus ghrelin treatment groups. After the rats were sacrificed, plasma samples were collected. Leydig cells were isolated and cultured with human chorionic gonadotropin (hCG, which is similar to LH and is used to stimulate Leydig cells to synthesize testosterone), 8-bromoadenosine 3′,5′-cyclic monophosphate (8-Br-cAMP, which is an activator of cyclic adenosine monophosphate-dependent protein kinase), or forskolin (an activator of adenylyl cyclase in a wide variety of cell types). Compared with normal treatment, ghrelin treatment in diabetic rats markedly increased plasma testosterone levels by 3.75-fold ( P < 0.05), Leydig cell testosterone secretion by 2.8-fold ( P < 0.05), GnRH-mediated LH release from the anterior pituitary by 2.95-fold ( P < 0.05), and StAR expression by 1.96-fold ( P < 0.05) in testicular Leydig cells. These findings indicated that ghrelin enhanced testosterone production in diabetic rats, which was partially achieved by the hypothalamic–pituitary–gonadal axis and StAR. This study emphasized the potential use of ghrelin as a treatment for improving testosterone levels and gonadal function in individuals with diabetes. Lay summary This study explored how a hormone known as ghrelin (which is mainly produced in the stomach) may help in regulating testosterone levels. Researchers examined male rats in four groups, including diabetic rats treated with ghrelin, and discovered that ghrelin increased testosterone production in diabetic rats by improving the communication between the brain, pituitary gland, and testes. This hormone also helped specific cells in the testes to function more effectively. The diabetic rats treated with ghrelin exhibited notable increases in testosterone levels and improved hormone function. These findings suggest that ghrelin could potentially help to address hormonal imbalances related to diabetes and improve reproductive health. This research highlights the potential benefits of ghrelin in addressing hormonal imbalances.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TestosteroneGhrelinLeydig CellsDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 1AnimalsMaleRats, Sprague-DawleyRatsTestisSteroidogenic Acute Regulatory ProteinLuteinizing Hormone

Stichwörter der Autor:innen

LHLHRSTZTErats

Substanzen

TestosteroneGhrelinSteroidogenic Acute Regulatory ProteinLuteinizing Hormone

Autor:innen und Institutionen

  • Department of Optometry, MacKay Junior College of Medicine, Nursing, and Management, Taipei, Taiwan.
  • Department of Physiology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Department of Medical Research, Shuang Ho Hospital, Taipei Medical University, New Taipei, Taiwan.
  • Continew Medical, INC., Taipei, Taiwan.
  • Medical Center of Aging Research, China Medical University Hospital, Taichung, Taiwan.
  • Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan.

ORCID-Profile: Chien-Chen Lu, Paulus S Wang

Förderung

  • Ministry of Science and Technology, Taiwan, ROC

Zitieren

APA

Lu, C. C., Chang, C. H., Chou, J. C., Yu, P. L., & Wang, P. S. (2025). Regulatory mechanism of ghrelin on testosterone secretion in type 1 diabetic rats. Reproduction and Fertility. https://doi.org/10.1530/raf-24-0087

Vancouver

Lu CC, Chang CH, Chou JC, Yu PL, Wang PS. Regulatory mechanism of ghrelin on testosterone secretion in type 1 diabetic rats. Reproduction and Fertility. 2025. doi:10.1530/raf-24-0087

BibTeX
@article{Lu2025,
  author = {Lu, Chien-Chen and Chang, Chia-Hsin and Chou, Jou-Chun and Yu, Po-Ling and Wang, Paulus S},
  title = {Regulatory mechanism of ghrelin on testosterone secretion in type 1 diabetic rats},
  journal = {Reproduction and Fertility},
  year = {2025},
  doi = {10.1530/raf-24-0087}
}
Kostenlos starten →